Toma, S <br/><br/>
Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.  [electronic resource] 

 -  International journal of oncology  Nov 2000 
 - 991-1000 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1019-6439 
<br/><br/><label>Standard No.: </label>10.3892/ijo.17.5.991  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aneuploidy<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Area Under Curve<br/>Bone Marrow Diseases--chemically induced<br/>Breast Neoplasms--chemistry<br/>Carcinoma--chemistry<br/>Drug Administration Schedule<br/>Drug Interactions<br/>Female<br/>Follow-Up Studies<br/>Headache--chemically induced<br/>Humans<br/>Hypercholesterolemia--chemically induced<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Ki-67 Antigen--analysis<br/>Mastectomy<br/>Middle Aged<br/>Neoplasm Proteins--analysis<br/>Receptors, Retinoic Acid--analysis<br/>Receptors, Steroid--analysis<br/>Recombinant Proteins<br/>Safety<br/>Tamoxifen--administration & dosage<br/>Transforming Growth Factor beta--analysis<br/>Transforming Growth Factor beta1<br/>Treatment Outcome<br/>Tretinoin--administration & dosage